Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2025 09:29 ET | Source: Research and Markets

Myocardial Infarction Market Forecast Report 2025-2033 Featuring Major Players - Pfizer, BMS, AstraZeneca, Merck KGaA., Daiichi Sankyo, Novartis, Genentech, Amgen, Regeneron, Takeda

Dublin, April 02, 2025 (GLOBE NEWSWIRE) -- The "Myocardial Infarction Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...
January 17, 2025 09:02 ET | Source: Research and Markets

2025 Report | Critical Limb Ischemia Treatment Market Poised for Robust Growth, Projected to Reach USD 6.36 Billion by 2030

Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Critical Limb Ischemia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...
June 20, 2024 06:28 ET | Source: Research and Markets

Myodyal Infarction Market Forecast to Reach $3.43 Billion by 2032: Global Analysis by Drug Class, Distribution Channel, Region and Company

Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global Myocardial Infarction Market Report by Drug Class, Distribution Channels, Regions and Company Analysis 2024-2032" report has been added to ...
November 16, 2023 07:28 ET | Source: Research and Markets

Blood Preparation Market Size, Share & Trends Analysis Report 2023- Global Forecast to 2030 Featuring Pfizer, Bristol-Myers Squibb, Leo Pharma, Sanofi, Xiamen Hisunny Chemical, AstraZeneca, Baxter

Dublin, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The "Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And...
November 02, 2023 05:03 ET | Source: Research and Markets

ESG Perspective: Sustainability Gains Importance in the Antithrombotic/Anticoagulant Drugs Market

Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global...
September 21, 2023 09:58 ET | Source: Research and Markets

Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028

Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
April 20, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled

PRINCETON, N.J., April 20, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
March 09, 2023 16:15 ET | Source: CytoSorbents

CytoSorbents Reports Fourth Quarter and Full Year 2022 Results

Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2022 continues in Q1 2023 to date, with expectation of sales growth in 2023 PRINCETON, N.J., March...
May 17, 2021 04:38 ET | Source: Research and Markets

Insights on the $87+ Billion Cardiovascular Drugs Global Market to 2030 - Identify Growth Segments for Investment

Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Cardiovascular Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...
May 04, 2021 04:28 ET | Source: Research and Markets

China Apixaban Market Report 2021: Analysis of Major Manufacturers 2016-2020, Prices 2020-2021 & Prospects 2021-2025

Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Apixaban Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The sales revenue of Apixaban...